This Viewpoint describes reforms to the ways the National Health Service (NHS) appraises cost-effectiveness and coverage of cancer drugs in England and Wales, the role of the National Institute for Health and Care Excellence (NICE) in the process, and changes in drug approval rates and access to new drugs as a result.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2BIhWGd
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
The population of American Indians and Alaska Natives (AIAN) in the USA, which comprise about 5 million individuals, have worse health outco...
-
Abstract Purpose C-reactive protein and procalcitonin are reliable early predictors of infection after colorectal surgery. However, the ...
-
. The copytext for the following essays is the 1777 edition of the Essays and Treatises on Several Subjects. The essays themselves all appea...
-
[prev in list] [next in list] [prev in thread] [next in thread] List: enlightenment-svn Subject: E SVN: raster trunk/illume/dicts From: Enli...
-
Strangers on the Mountain They had lived in the woodlands, twenty-five miles from New York City, for generations. Why were people so afraid ...
-
Famous Quotes: Hand Picked Funny, Inspirational and Love Quotes. Looking for the best famous quotes? from #AlexandrosSfakianakis via Alexa...
-
SMARTCOCKPIT; Our #1 goal, since 2000, is to offer the most extensive online aviation resource to worldwide professional pilots. We desire t...
-
Abstract Monitoring blood loss is important for management of surgical patients. This study reviews a device (Triton) that uses computer a...
-
<span class="paragraphSection"><div class="boxTitle">Abstract</div>Despite many advances in the study ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου